🇺🇸 FDA
Patent

US 11174268

Benzenesulfonamide compouds and their use as therapeutic agents

granted A61KA61K31/395A61K31/427

Quick answer

US patent 11174268 (Benzenesulfonamide compouds and their use as therapeutic agents) held by Xenon Pharmaceuticals Inc. expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Nov 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K31/395, A61K31/427, A61P, A61P25/08